Narrow Results

The article states a list of venture capitalists in Shanghai.

Prima Expands Its IP Portfolio.

Sinopharma Industry Co. Established.

Sino-Swed Reports Growth in Exports.

Shanghai Pharmaceutical Develops Painkiller Effective for Four Months.

QiLu Antibioticos Achieves Record Sales and Exports.

Dawnrays Pharmaceutical Raises US$150 Million from IPO.

Ono Starts Phase I Clinical Studies for New HIV Drug.

Singapore’s National Cancer Center and Genedata Announce Collaboration on Cancer Diagnostics.

Eiffel's New SCF Facility in Operation.

Non Bactericidal Antibiotics.

C-Pulse Heart Device Testing Progressing.

Mesoblast Boosted by Successful Closing of IPO.

China's Changing IPR Landscape.

Investment Hotspot: China's OTC Market.

Matrix Laboratories Close to Inking Landmark Contract Manufacturing Deal.

Sosei US Subsidiary Focuses on CNS Therapy Development.

Novartis Contemplates Setting up Research Base in India.

Latest Pharma Merger: Dainippon and Sumitomo.

Eisai Targets on Anti-Hepatitis Drug Market in China.

Zimmer Targets at Asian Aging Population.

ES Cell Receives Million Dollar Grant.

Combing to be Regional Vaccine Manufacturing Center.

No abstract reveived.

Nandan Biomatrix Plans for IPO.

Takeda Phamaceutical Boosts Presence in US Drug Discovery Market.

Acupuncture in a Pill.

Biosensors Expands Its Presence in Asia-Pacific.

Miltenyi Biotec Establishes Asia Pacific Headquarters in Singapore.

Australian Drug Discovery Company, Incitive Ltd, Announces Initial Public Offer.

Biosignal Collaborates with Ciba Specialty Chemicals.

Brisbane's Tissue Therapy Partners Canada's QSV Biologics.

Cellestis Signs Agreements on TB and Cytomegalovirus with FIND.

Mesoblast Obtained an Exclusive Worldwide License to Commercialize New Drug-eluting Stent Technology.

Narhex Life Sciences Ltd: An Emerging Australian Biotechnology Company.

Norwood Immunology Collaborates with Australian Stem Cell Center and Monash University.

Premier Bionics' Subsidiary Medic Vision Team up with the University of Melbourne and the CSIRO.

PharmaEng signs LOI to Purchase Beijing Lixin PharmaTech.

Japan's Bioventures Today—Noas Medical Co Ltd.

Incitive to Prepare for IPO.

Scigen Acquires Manufacturing Facility from Shreya Biotech.

Taiwan's New Discovery on Cancer.

Japan's Kissei Licenses Glufast to Elixir.

Generic Pharma Giant Teva Increases Stake in Chinese Biotech Firm.

Living Cell Technologies Awarded NZ$2.7 Million Investment through the Foundation for Research, Science and Technology.

Bionomics Wins A$3.7 Million AusIndustry Grant.

Singapore to Invest $7.5 Billion over Five Years on Research and Development.

Queensland Projects Win A$1.6 million Funding.

BAYER HealthCare and Economic Development Board to foster translational and clinical research for diseases prevalent in Asia

Ludwig Cancer Research and University of Oxford launch Cancer Immunotherapy Spinout

OmniComm Systems® Announces Reseller Agreement with Tri-I Biotech Shanghai Inc. Market Leading Life Sciences Consultancy to Resell OmniComm’s TrialOne® eSource Solution

Resverlogix Closes License Agreement and Enters Into Definitive Stock Purchase Agreement with Hepalink

Immunovaccine and PharmAthene Sign Exclusive Worldwide License Agreement to Develop and Commercialize an Anthrax Vaccine Formulated in DepoVax™

Commonwealth Financing Authority Announces New Alternative, Clean Energy Investment

ContraFect Corporation Announces Issuance of Key Patent Covering Novel Lysin Technology

M Pharmaceutical Inc. Rebrands Itself to Better Reflect Growing Family of Biomedical Technologies

Sustainable Apparel Coalition Recognizes SCS Global Services as Approved Verifier for New Pilot Program

StemCell United Announces Plans for PO and Listing on ASX

Roche Diagnostics Strengthens Footprint in Asia Pacific